If a pharmaceutical company develops a highly selective antagonist for the neurokinin-1 (NK1) receptor in the dorsal horn, which consequence follows regarding pain perception?

💡 Explanation

Blocking the NK1 receptor prevents substance P from binding, which reduces the transmission of pain signals in the spinal cord because substance P is a key neurotransmitter in nociceptive pathways. Therefore, pain perception is diminished, rather than enhanced peripheral sensitization or increased inflammation.

• A woman experiences consistently short luteal phases (8 days). Which consequence becomes likely during her attempts to conceive?
• Why does chronic inflammation, triggered by persistent exposure to inhaled silica particles, lead to sustained activation of the NF-κB pathway in lung epithelial cells?
• If the cystic duct becomes blocked by a gallstone, which consequence follows regarding digestive processes?
• A hiker stranded in a desert with limited water experiences increased plasma osmolality. What effect dominates as this osmolality climbs?
• Why does the countercurrent multiplier system in the renal medulla require specific descending and ascending limb permeability characteristics for efficient urine concentration?
• If a demyelinating disease slows action potential propagation in a motor neuron, which consequence follows for muscle contraction?